Zymeworks FY 2023: revenue $76.0M, down 82%; diluted EPS −$1.72

Key figures from this report

These are the numbers Zymeworks reported for the year ended Dec 31, 2023, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$76.0M−82% from $412.5M in FY 202210-K income statement, on EDGAR
2. Net income−$118.7M−195% from $124.3M in FY 202210-K income statement, on EDGAR
3. Diluted EPS−$1.72−191% from $1.90 in FY 202210-K income statement, on EDGAR
4. Cash and cash equivalents$157.6M−61% from $400.9M in FY 2022Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
5. Cash from operations−$118.3M−182% from $144.1M in FY 202210-K cash flow statement, on EDGAR

Every year in the financial tables